ClinConnect ClinConnect Logo
Search / Trial NCT06322251

Identification of Interpesonal Violence

Launched by REGION STOCKHOLM · Mar 19, 2024

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Youth Pregnancy Primary Care Virtual Patient Interpersonal Violence

ClinConnect Summary

This clinical trial is focused on improving how healthcare professionals identify individuals who may be experiencing intimate partner violence (IPV) in primary care settings. The study will test three different approaches: using a standardized questionnaire to screen patients for IPV, training staff with virtual patients that represent IPV situations, and combining both the questionnaire and virtual training. The goal is to see which method helps healthcare workers recognize and respond to victims of IPV most effectively.

Healthcare staff who work directly with patients, like doctors, nurses, midwives, and social workers, are eligible to participate in this study. Those who choose to join will apply one of the three methods in their work environment. Before and after using the methods, researchers will measure how well the staff can identify patients experiencing IPV. Additionally, focus group discussions will help gather feedback on which approach was seen as the most effective. This research aims to enhance support for individuals facing violence in their relationships, ultimately improving their care in primary health settings.

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • All health care staff who meet patients at the included study sites are elegible for the study
  • Midwives, MDs, psychologists, social workers, nurses etc.
  • Exclusion criteria:
  • - Health care staff who does not want to participate

About Region Stockholm

Region Stockholm is a leading healthcare authority committed to advancing medical research and improving patient care through innovative clinical trials. As a sponsor, Region Stockholm collaborates with hospitals, research institutions, and industry partners to facilitate the development of new therapies and treatment protocols. With a focus on quality, safety, and ethical standards, the organization aims to enhance health outcomes for the diverse population of Stockholm and beyond, leveraging cutting-edge research to translate scientific discoveries into effective healthcare solutions.

Locations

Linköping, , Sweden

Patients applied

0 patients applied

Trial Officials

Mia M Barimani, Professor

Principal Investigator

Linkoeping University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported